- Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcomaRobert J Canter
Department of Surgery, Division of Surgical Oncology, University of California Davis Medical Center, 4501 X Street, Sacramento, CA 95817, USA
BMC Cancer 14:756. 2014..We hypothesized that TKIs would have differential effects on CSC populations depending on their mechanism of action (anti-proliferative vs. anti-angiogenic)...
- A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiformeArta M Monjazeb
Department of Radiation Oncology, UC Davis School of Medicine, Sacramento, CA 95817, USA
Int J Radiat Oncol Biol Phys 82:743-8. 2012..To describe the results of a Phase I dose escalation trial for newly diagnosed glioblastoma multiforme (GBM) using a hypofractionated concurrent intensity-modulated radiotherapy (IMRT) boost...
- The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complicationsArta Monir Monjazeb
Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA 95816, USA
Semin Radiat Oncol 23:60-73. 2013..Late toxicities are less well defined, but commonly include esophageal, pulmonary, and cardiac toxicities...